Medicine

Visionary Scientist James Till, Father of Stem Cell Science, Leaves a Legacy That Saves Millions—and Ignites the Future of Medicine Discover how University of Toronto’s James Till transformed stem cell…

BioNTech transitions focus from COVID-19 vaccines to cancer therapies, particularly mRNA-based treatments. Despite declining profits—from 1.90 euros to 1.08 euros per share—BioNTech exceeded earning forecasts, boosting optimism. Annual performance shows…